What is Lucid Diagnostics's investing cash flow?

Lucid Diagnostics (LUCD) reported investing cash flow of -$215K in Q1 2026.

How has Lucid Diagnostics's investing cash flow changed year-over-year?

Lucid Diagnostics's investing cash flow decreased by 131.2% year-over-year, from -$93K to -$215K.

What is the long-term trend for Lucid Diagnostics's investing cash flow?

Over 4 years (2021 to 2025), Lucid Diagnostics's investing cash flow has grown at a -30.9% compound annual growth rate (CAGR), from -$862K to -$197K.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Lucid Diagnostics LUCD Investing Cash Flow

Investing Cash Flow at other companies

Castle BiosciencesCSTL

-$25.8M-15.0%

Guardant HealthGH

$699.42M+131%

Biodesix, Inc.BDSX

-$144K-5.1%

Insight Molecular Diagnostics Inc. Common StockIMDX

-$613K-99.7%

Fulgent Genetics, Inc.FLGT

$10.94M-60.6%

Personalis, Inc.PSNL

-$46.01M-104%

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's investing cash flow?: Lucid Diagnostics (LUCD) reported investing cash flow of -$215K in Q1 2026.
How has Lucid Diagnostics's investing cash flow changed year-over-year?: Lucid Diagnostics's investing cash flow decreased by 131.2% year-over-year, from -$93K to -$215K.
What is the long-term trend for Lucid Diagnostics's investing cash flow?: Over 4 years (2021 to 2025), Lucid Diagnostics's investing cash flow has grown at a -30.9% compound annual growth rate (CAGR), from -$862K to -$197K.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.